China Jo-Jo Drugstores (CJJD) Reports Q2 EPS of $0.04
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
China Jo-Jo Drugstores (NASDAQ: CJJD) reported Q2 EPS of $0.04, versus $0.00 reported last year. Revenue for the quarter came in at $20.2 million, versus $22.6 million reported last year.
Mr. Lei Liu, China Jo-Jo's Chairman and CEO, commented, "Our gross margin continued to expand, benefiting from more vendor rebates attributable to our focused marketing efforts in promoting brand-name pharmaceutical products, as we believe selling these products enhances our store popularity and customer loyalty. During the quarter, we achieved sales volume with certain brand pharmaceutical suppliers and received substantial rebates. In addition, now that the G20 summit is behind us, we have normalized our marketing activities and expect a rebound in retail sales in the third quarter."
For earnings history and earnings-related data on China Jo-Jo Drugstores (CJJD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- Emcore (EMKR) Tops Q3 EPS by 1c
- NV5 Global (NVEE) Announces Acquisition of CivilSource
Create E-mail Alert Related CategoriesEarnings, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!